[
    [
        {
            "time": "",
            "original_text": "康泰生物：预计一季度净利同比大幅下滑 盈利能力下降",
            "features": {
                "keywords": [
                    "康泰生物",
                    "一季度",
                    "净利",
                    "同比",
                    "大幅下滑",
                    "盈利能力",
                    "下降"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康泰生物：预计一季度净利同比大幅下滑 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康泰生物(300601.SZ)：一季度净利润预降85%-100% 盈利能力下降",
            "features": {
                "keywords": [
                    "康泰生物",
                    "300601.SZ",
                    "一季度",
                    "净利润",
                    "预降",
                    "85%",
                    "-",
                    "100%",
                    "盈利能力",
                    "下降"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康泰生物(300601.SZ)：一季度净利润预降85%-100% 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 1,
                "Importance": 10,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "康泰生物：一季度预计净利润同比下降85.0%-100.0% 盈利能力下降",
            "features": {
                "keywords": [
                    "康泰生物",
                    "一季度",
                    "预计",
                    "净利润",
                    "同比下降",
                    "85.0%",
                    "-",
                    "100.0%",
                    "盈利能力",
                    "下降"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康泰生物：一季度预计净利润同比下降85.0%-100.0% 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 1,
                "Importance": 10,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]